The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Patients’ Accounts of Increased “Connectedness” and “Acceptance” After Psilocybin for Treatment-Resistant Depression
Abstract
Objective: To identify patients’ perceptions of the value of psilocybin as a treatment for depression. Method: Twenty patients enrolled in an open-label trial of psilocybin for treatment-resistant depression participated in a semistructured interview at 6-month follow-up. Thematic analysis was used to identify patients’ experiences of the treatment and how it compared with previous treatments. Results: Two main change processes were identified in relation to the treatment. The first concerned change from disconnection (from self, others, and world) to connection, and the second concerned change from avoidance (of emotion) to acceptance. A third theme concerned comparison between psilocybin and conventional treatments. Patients reported that medications and some short-term talking therapies tended to reinforce their sense of disconnection and avoidance, whereas treatment with psilocybin encouraged connection and acceptance. Conclusions: These results suggest that psilocybin treatment for depression may work via paradigmatically novel means, antithetical to antidepressant medications, and some short-term talking therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A limitation of the CEQ is that it measures challenging emotions, memories, or both without addressing their potential resolution. Therefore, it cannot assess the potential value of overcoming any emotional challenges experienced under the influence of psychedelics (Watts et al., 2017).”
From Assessment of the acute subjective psychedelic experience: A review of patient-reported outcome measures in clinical research on classical psychedelics (2024) · cites this paper as Watts et al., 2017
In the citing paper
“Therapeutic outcomes appear strongly influenced by psychological “set” (mindset, expectations, preparation), environmental “setting,” and structured post-session integration (96, 99, 107, 108), highlighting the central role of context, support, and integration in optimizing benefit.”
From The therapeutic role of self-transcendence in moral injury recovery: theory, mechanisms, and clinical implications (2026) · cites this paper as [99]
In the citing paper
“In qualitative interviews, participants identified this tri-dimensional factor as a key element underlying the therapeutic effect of PAT [61, 62], including reduced craving and substance use in individuals with addiction [62].”
In the citing paper
“These emotions largely cohered with previous observations in other psilocybin studies (36–42).”
In the citing paper
“These outcomes are in line with previous reports from participants of clinical trials, who described a notable shift from emotional avoidance to acceptance, after receiving psilocybin-assisted psychotherapy for treatment-resistant depression [57].”
From The psychological processes of classic psychedelics in the treatment of depression: a systematic review protocol (2022) · cites this paper as [57]
In the citing paper
“Their use can help individuals break through emotional barriers, confront past traumas, and develop a deeper sense of self-awareness and connection with others (Watts et al. 2017;Carhart-Harris et al. 2018).”
From Authenticity and Love Drugs: Insights from Psychedelic Therapy (2026) · cites this paper as Watts et al. 2017
In the citing paper
“After treatment, many reported to be able to “re-connect” with family members, friends, strangers, and even people who had wronged them.”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
In the citing paper
“Patients identified this increased connection as one of two main change processes in relation to treatment (32)”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
In the citing paper
“Yet, the same patients reported that they experienced a sense of disconnection from others as particularly distressing before psilocybin-assisted treatment (32).”
From Modulation of Social Cognition via Hallucinogens and “Entactogens” (2019) · cites this paper as [32]
Citations
Cites
(1998) · Sage eBooks · Cited by 38,631
Basics of Qualitative Research (3rd ed.): Techniques and Procedures for Developing Grounded Theory
Corbin, J., & Strauss, A. (2008) · SAGE · doi:10.4135/9781452230153 · Cited by 12,136
Successful Qualitative Research: A practical guide for beginners
Jamieson, J., Braun, V., & Clarke, V. (2014) · QMiP Bulletin · doi:10.53841/bpsqmip.2014.1.18.39 · Cited by 6,673
Successful qualitative research: A practical guide for beginners
(2016) · QMiP Bulletin · doi:10.53841/bpsqmip.2016.1.21.48 · Cited by 4,033
Client-Centered Therapy: Its Current Practice, Implications and Theory
Rogers, C. R. (1951) · Cited by 2,416
Griffiths, R. R., Johnson, M. W., Carducci, M. A., Umbricht, A., Richards, W. A., Richards, B. D., Cosimano, M. P., & Klinedinst, M. A. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675513 · Cited by 2,201 · cited 4×
“…formal, quantitative analyses of the utility of psilocybin (Carhart-Harris, Bolstridge, et al., 2016; Carhart-Harris, 2017; Gasser et al., 2014; Griffiths et al., 2016; Ross et al., 2016) and should help inform and enrich understanding of this novel treatment and its mechanisms of action,…”
InfluentialClient-centered therapy; its current practice, implications, and theory.
Miles, D. W. (1952) · Psychological Bulletin · doi:10.1037/h0053095 · Cited by 2,122
Nichols, D. E. (2016) · Pharmacological Reviews · doi:10.1124/pr.115.011478 · Cited by 1,762
How important are the common factors in psychotherapy? An update
Wampold, B. E. (2015) · World Psychiatry · doi:10.1002/wps.20238 · Cited by 1,728 · cited 1×
“…to play a role in determining treatment outcomes (Greenberg, Constantino, & Bruce, 2006; Visla, Constantino, Newkirk, Ogrodniczuk, & Söchting, 2016; Wampold, 2015; Wampold et al., 2005) and it is likely that many of the patients in this trial had positive expectations and/or experienced a positive…”
Ross, S., Bossis, A., Guss, J., Agin-Liebes, G., Malone, T., Cohen, B., Mennenga, S. E., Belser, A., Kalliontzi, K., Babb, J., et al. (2016) · Journal of Psychopharmacology · doi:10.1177/0269881116675512 · Cited by 1,698
Research works printed but not linked: 5
- Frankl V. E., 1961, Confinia Psychiatrica, 4, 99
- Goldsmith N., 2011, Psychedelic healing: The promise of entheogens for psychotherapy and spiritual development
- Grof S., 1980, LSD psychotherapy
- Meckel Fischer F., 2015, Therapy with substance: Psycholytic psychotherapy in the twenty first century
- Stolaroff M., 2004, The secret chief revealed: Conversations with Leo Zeff
Cited by
Sorted by citations
Items 401–500 of 585
Facilitating real-life creative insight through psychedelic virtual realityPreprint
Siimon, T., Tulver, K., Kaup, K., Vasser, M., & Aru, J. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/zth7f · Cited by 4
Finkelstein, C., Soha, O., Roy, A., Phillipou, A., & Rossell, S. L. (2023) · Research Square · doi:10.21203/rs.3.rs-3189970/v1 · Cited by 2
Mathai, D. S., Roberts, D. E., Nayak, S. M., Sepeda, N. D., Lehrner, A. L., Johnson, M. W., Lowe, M. X., Jackson, H., & Garcia‐Romeu, A. (2023) · doi:10.31234/osf.io/hm6jn · Cited by 2
From psychache to neuroplasticity: A unified rescue-repair model of Ketamine’s anti-suicidal action
Domany, Y., & Solomon-Shashua, A. (2026) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2026.106804 · Cited by 2
Strika-Bruneau, L., Fauvel, B., Dupuis, D., & Benyamina, A. (2023) · L Évolution Psychiatrique · doi:10.1016/j.evopsy.2023.01.003 · Cited by 1
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0009 · Cited by 1
How Psychedelics Can Increase Moral Concern
Dillion, D., Puryear, C., & Gray, K. J. (2024) · Oxford University Press eBooks · doi:10.1093/oxfordhb/9780192844064.013.22 · Cited by 1
The way of O: phenomenology of psychedelic use and the path to ultimate reality
Miller, C. W. T. (2024) · Psychodynamic Practice · doi:10.1080/14753634.2024.2371787 · Cited by 2
The psychedelic experience: a new perspective, a new attitude towards the world
Ballesteros, V. (2024) · Oxford University Press eBooks · doi:10.1093/oso/9780192898371.003.0009 · Cited by 1
Suay, D., Aicher, H., Singer, B., Mueller, M. J., Jelusic, A., Calzaferri, L., Springfeld, P., Dornbierer, D., & Scheidegger, M. (2025) · Journal of Psychopharmacology · doi:10.1177/02698811251353256 · Cited by 1
Martens, M., Cunha, B. G., Erritzøe, D., Nutt, D., Carhart-Harris, R. L., & Harmer, C. J. (2025) · Translational Psychiatry · doi:10.1038/s41398-025-03693-w · Cited by 5
Self-citationde Carvalho, L. L., Encantado, J., van Elk, M., Moller, A. C., Cornelius, T. M., Timmermann, C., Veiga, D., & Teixeira, P. J. (2025) · Scientific Reports · doi:10.1038/s41598-025-25818-3 · Cited by 1
Pincombe, J., Williams, M. L., Carruthers, S. P., & Rossell, S. L. (2025) · Psychedelic Medicine · doi:10.1177/28314425251394012 · Cited by 1
Kirlić, N., Atli, M., Mistry, S. J., Gold, M., & Goodwin, G. M. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000002119 · Cited by 1
Rich, R., Laird, K. T., Siddarth, P., Youssef, B., Schwartz, G. M., Ramos, A., Sergi, K., Linton, M., Schwartzberg, L., Kelly, D. F., et al. (2025) · Psychedelic Medicine · doi:10.1177/28314425251387655 · Cited by 1
Catalysing transformational change through compound nature connectedness interventions
Pritchard, M., Tovey, P., Tickell, P., & Oliver, T. H. (2025) · Ambio · doi:10.1007/s13280-025-02328-0 · Cited by 2
Luoma, J. B., LeJeune, J. T., Pilecki, B. C., Yi, K., & Lear, M. K. (2026) · Neuroethics · doi:10.1007/s12152-026-09631-x · Cited by 1
Koning, E., Gamberg, S., & Keshen, A. R. (2026) · Behavioral Sciences · doi:10.3390/bs16030376 · Cited by 1
Wrathall, D. J., Gosnell, H., Wickson, F., Spanger‐Siegfried, E., & Associates* (2026) · Action Research · doi:10.1177/14767503251404263 · Cited by 1
Negrine, J. J., Bright, S. J., Barratt, M. J., Pennell, M., Barnett, A., Bennett–Levy, J., & Piatkowski, T. M. (2026) · Drugs Education Prevention and Policy · doi:10.1080/09687637.2026.2645025 · Cited by 1
Kazdan, J., Ladha, K. S., & Husain, M. I. (2026) · Pharmacology Research & Perspectives · doi:10.1002/prp2.70238 · Cited by 2
Psycholytic Therapy Using LSD: a Realist Review
Grime, H., & Drini, E. (2026) · Brain and Behavior · doi:10.1002/brb3.71187 · Cited by 1
Kurniawan, S. J., Wiyono, B. D., Naqiyah, N., & Supriyanto, A. (2026) · Palliative & Supportive Care · doi:10.1017/s147895152610220x · Cited by 1
Low, F., & Earleywine, M. (2026) · Journal of Psychoactive Drugs · doi:10.1080/02791072.2026.2673844 · Cited by 2
Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review
da Cruz, L. V. M., Beserra, F. R., FREIND, J. M. K., Rodrigues, S. E., & Mograbi, D. C. (2026) · Journal of Clinical Psychology · doi:10.1002/jclp.70167 · Cited by 1
Postránecká, Z., Lucký, M., Mravčík, V., & Páleníček, T. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00514 · Cited by 1
From fragmentation to communion: Western dis-integration and indigenous ecosophies
Gebara, M. F. (2026) · Journal of Psychedelic Studies · doi:10.1556/2054.2026.00528 · Cited by 2
Erdmann, L., Breitenstein, B., Badanova, M., Telschow, L., Havenith, M. N., & Dziobek, I. (2026) · Frontiers in Psychology · doi:10.3389/fpsyg.2026.1777341 · Cited by 1
Strika-Bruneau, L., Elhssaini, C., Fauvel, B., Kervadec, E., Bezo, A., Amirouche, A., Benyamina, A., & Roméo, B. (2026) · Journal of Psychopharmacology · doi:10.1177/02698811261473436 · Cited by 1
Possível uso da Psilocibina no tratamento psiquiátrico, incluindo sequelas da COVID-19
Bonifácio, M. C. A. C., Bento, P. B. B., Trevisan, K., Cristina-Pereira, R., Magri, M. P. D. F., & Aversi‐Ferreira, T. A. (2021) · Research Society and Development · doi:10.33448/rsd-v10i11.19259 · Cited by 1
Golia, K. (2022) · Consciousness Spirituality & Transpersonal Psychology · doi:10.53074/cstp.2022.37 · Cited by 1
Ezeaka, U. C., Kim, H. J. J., & Laprairie, R. B. (2023) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026623666230705151922 · Cited by 1
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0001 · Cited by 1
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0005 · Cited by 1
Psychiatric power and the ADHD experience
Joseph, A. (2021) · Canada Watch · doi:10.25071/xv35w718 · Cited by 1
Psychedelic-assisted grief therapy: a mixed-method case study
Sabucedo, P., Evans, C., Nicolson, D., Farré, M., & González, D. (2024) · Mortality · doi:10.1080/13576275.2024.2434456 · Cited by 2
Mental disorder and its treatment as a transformative experience
Villiger, D. (2025) · Phenomenology and the Cognitive Sciences · doi:10.1007/s11097-025-10059-6 · Cited by 1
Identification and management of anxious depression in patients with treatment-resistant depression
Hershenberg, R., Rapaport, M. H., & Weischedel, K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-824067-0.00029-3 · Cited by 1
Kähönen, J. (2020) · Työväentutkimus Vuosikirja · Cited by 1
Ferreira, J. P. E., Bortoli, S., & Pereira, A. V. (2022) · Revista Virtual de Química · doi:10.21577/1984-6835.20220053 · Cited by 1
Psychedelic therapy for body dysmorphic disorder
Johnson, S., & Letheby, C. (2022) · Journal of Psychedelic Studies · doi:10.1556/2054.2022.00200 · Cited by 1
Apud, I. (2023) · Studies in Psychology Estudios de Psicología · doi:10.1080/02109395.2022.2163776 · Cited by 1
Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)Preprint
Teixeira, P. J., Johnson, M. W., Timmermann, C., Watts, R., Erritzøe, D., Douglass, H. M., Kettner, H., & Carhart-Harris, R. L. (2021) · doi:10.31234/osf.io/8vks6 · Cited by 1
Self-citationA Needs Assessment of Older Hispanics in Omaha, Nebraska
DiMartino, D. R. (1979) · DigitalCommons@UNO · Cited by 1
Perkins, D., Ruffell, S., Day, K., Pinzon, D., & Sarris, J. J. (2022) · doi:10.31219/osf.io/e5tjc · Cited by 1
Pratscher, S. D. (2020) · MOspace Institutional Repository (University of Missouri) · doi:10.32469/10355/78090 · Cited by 1
Michael, P. (2021) · The Journal of near-death studies · doi:10.17514/jnds-2021-39-3-p161-183 · Cited by 1
Journey To The Centre Of The Mind: Psychedelic Treatment of Mental Health in Aotearoa
Lutyens, D. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.21904854 · Cited by 2
Virgilio, V. D., Minerbi, A., Fletcher, J., Virgilio, A. D., Aggerwal, S., Sheen, L., Deol, J. K., & Gupta, G. (2023) · medRxiv · doi:10.1101/2023.02.12.23285814 · Cited by 1
Ibogaine as a Treatment For Alcohol Use Disorder: a Preclinical Investigation
Falkenhaug, S. (2023) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.24225145 · Cited by 1
Pincombe, J., Williams, M. L., Carruthers, S. P., & Rossell, S. L. (2024) · doi:10.31234/osf.io/ga9p2 · Cited by 1
Bell, A. K., Watt, B. R., Flores, A. L., Rodriguez, S. R., Smith, D. T., & Stauffer, C. S. (2025) · Research Square · doi:10.21203/rs.3.rs-5908748/v1 · Cited by 1
Fleming, W. H. (2026) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2026.1701564
Bahi, C. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2007.08429 · Cited by 1
Johansen, L., Liknaitzky, P., Nedeljkovic, M., Mastin‐Purcell, L., & Murray, G. (2020) · Research Square · doi:10.21203/rs.3.rs-121894/v1
L’Appel de la forêt : étude exploratoire des trajectoires des néo-usagers d’ayahuasca
Beslon, B., Wagner, V., & Acier, D. (2021) · Annales Médico-psychologiques revue psychiatrique · doi:10.1016/j.amp.2021.03.002 · Cited by 1
The Effect of Psilocybin on Personality
LaBua, R. (2021) · CUNY Academic Works (City University of New York)
Naturalistic Entheogenics: Précis of Philosophy of PsychedelicsPreprint
Letheby, C. (2021) · doi:10.31234/osf.io/ztewb
Mertens, L., Wall, M. B., Roseman, L., Demetriou, L., Nutt, D., & Carhart-Harris, R. L. (2019) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2019.09.593
Self-citationForstmann, M., & Sagioglou, C. (2021) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/2489x
SUBJECTIVE EXPERIENCES OF CLASSIC PSYCHEDELIC SUBSTANCES USERS
Bienemann, B. (2022) · doi:10.17771/pucrio.acad.59337 · Cited by 1
РЕНЕСАНС ПСИХОДЕЛІЧНОЇ ТЕРАПІЇ ТА ЇЇ ЗНАЧЕННЯ ДЛЯ УКРАЇНИ
Matrenitsky, V. L. (2022) · Likarska sprava · doi:10.31640/2706-8803-2022-(3-4)-04 · Cited by 1
Et psykoanalytisk og et postmoderne perspektiv på selv/egoopløsning i en psykedelisk kontekstPreprint
Andersen, S. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/f26ce
Neue und experimentelle medikamentöse Therapieverfahren
Mertens, L. J., Hart, X. M., Scharf, D., Spangemacher, M., & Gründer, G. (2022) · Springer eBooks · doi:10.1007/978-3-662-65734-8_11
Should Psychedelic Drugs Be Offered as a Treatment for Mental Illness?
Zhang, R. (2023) · Journal of Humanities Arts and Social Science · doi:10.26855/jhass.2023.02.010
The psychotherapeutic component of psychedelic medicine
Higbed, L., & Sessa, B. (2023) · doi:10.1093/med/9780192863607.003.0002
Virgilio, V. D., Minerbi, A., Deol, J. K., Aggerwal, S., Safi, T., & Gupta, G. (2023) · medRxiv · doi:10.1101/2023.05.10.23289787
Montgomery, C., Amaya, I. A., & Schmidt, T. T. (2023) · doi:10.31234/osf.io/s6dnr
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0010
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0011
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0008
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0012
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0006
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0007
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0003
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0004
What Is Psychedelic Experience?
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0002
(2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.002.0005
Lyon, A. (2023) · Oxford University Press eBooks · doi:10.1093/oso/9780198843757.003.0003
Toledo, M. M. V. (2023) · Cultura y Droga · doi:10.17151/culdr.2023.28.35.5
Andersen, M. H., & Arenfeldt, S. K. (2023) · PsyArXiv (OSF Preprints) · doi:10.31234/osf.io/hyp87
Vanderijst, L., Hever, F., Buot, A., Dauré, C., Benoit, J., Hanak, C., Veeser, J., Morgiève, M., Campanella, S., Kornreich, C., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3829237/v1
Breeksema, J. J. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.912040905
Introduction to the EMBARK Approach
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0003
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0006
Bringing It Home and Carrying It Forward
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0009
Considerations Prior to Meeting With a Participant
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0005
INTRODUCTION: A New Approach for the Whole Person
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0001
Choosing Suggested Integration Goals
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0004
Working Within the EMBARK Domains Cheat Sheet
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0003
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0007
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0002
An Overview of Psychedelic-Assisted Therapy
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0002
Personal Care for the Therapist
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.005.0001
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0008
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.002.0004
EMBARK Mechanisms of Change in the Treatment of Depression
Brennan, B., & Belser, A. (2024) · Oxford University Press eBooks · doi:10.1093/9780197762622.003.0004
Metadata
- Authors
- Watts, R., Day, C., Krzanowski, J., Nutt, D., & Carhart-Harris, R.
- Affiliations
- Imperial College London (GB)
- Corresponding author
- Watts, Rosalind
- Venue
- Journal of Humanistic Psychology
- Publisher
- SAGE Publications
- Published
- 2017-06-19
- Volume
- 57
- Issue
- 5
- Pages
- 520-564
- ISSN
- 0022-1678 (ISSN-L)
- 1552-650X
- OpenAlex
- W2644260506
- Cited by
- 589
- References
- 54
- Citations by year
- 2026: 80 · 2025: 86 · 2024: 87 · 2023: 100 · 2022: 84 · 2021: 72 · 2020: 34 · 2019: 19 · 2018: 20 · 2017: 6
- FWCI
- 26.53
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Humanistic Psychology (publishedVersion)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Health › Religion, Spirituality, and Psychology
- Keywords
- psilocybin, treatment-resistant depression, patient experience, connectedness, acceptance, disconnection, emotional avoidance, antidepressants, psychotherapy, psychedelic therapy, mechanisms of change
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
